/Sponsor / Executive Profile

Dr. Richard Glickman

Executive

Aggregate Capital Deployment Matrix

Professional Biography

Dr. Richard M. Glickman has served as a member of enGene’s Board since April 24, 2023.

Total Capital Deployed

$102,500,000

Active / Searching Capital:
-

Transaction Volume

2 Transactions

Time-to-Liquidity (Months)

-

Merger Completion Rate

0.0%

Professional Network Intelligence

Frequent Underwriters

Frequent Associates

Top Sectors

  • biotechnology1 Deals
  • Biotechnology1 Deals

Syndicate Deal History

TickerCompanyStatusTrustPriceWarrantIPO DateTime LeftDeal ValueSectorBookrunner
ENGN
Forbion European Acquisition Corp.
closed
-
-
-Nov 2023Done
111.0M
biotechnology
Forbion Growth Sponsor FEAC I B.V.
FRBN
Forbion European Acquisition Corp.
announced
102.5M
$10.00
1/3Nov 2021-
111.0M
BiotechnologyUBS Securities LLC